期刊文献+

尿17-KS,17-OH在女性不孕症诊断中的应用

Value of Urinary 17-KS and 17-OH Level in the Diagnosis of Women with Infertility
下载PDF
导出
摘要 目的 探讨尿17-酮类固醇(17-KS)、尿17-羟类固醇(17-OH)与不孕的关系.方法 采用色谱-分光光度法测定130例不孕患者24 h尿中17-KS和17-OH的含量,同时测定健康对照组.结果 24 h尿17-KS和17-OH平均水平,不孕组明显高于正常对照组(P均<0.001).结论 不孕组尿17-KS和17-OH水平明显高于正常对照组,说明尿17-KS和17-OH排泄量增加与育龄妇女不孕间存在一定的相关性,可为临床提供有价值的参考数据,对临床诊断、治疗具有辅助意义. Objective To study the relationship between the 17-KS,17-OH and infertility. Methods By the Chromatography-Spectrophotometry,determined the level of the 17-KS and 17-0H in the urine for 24 hours of 130 patients with infertility,the control group was 42 cases of healthy women. Results The mean 17-KS and 17-OH levels were significantly higher in women with infertility compared with fertile subjects (P〈0. 001). Conclusion A significant difference in urine 17-KS and 17-OH levels between infertile and fertile women showed that 17-KS and 17-OH could be used as a diagnostic indicator for infertility of women. They may provide valuable data with clinical ,and support the clinical diagnosis of infertility in women.
出处 《现代检验医学杂志》 CAS 2010年第6期133-134,137,共3页 Journal of Modern Laboratory Medicine
关键词 17-酮类固醇 17-羟类固醇 不孕 肾上腺皮质 17-KS 17-OH infertility adrenal cortex
  • 相关文献

参考文献9

  • 1陈如钧 江鱼.不孕不育治疗学[M].上海:上海科学技术出版社,1997..
  • 2杨自更,张阳.226例不孕患者性激素水平变化及分析[J].放射免疫学杂志,2009,22(1):39-40. 被引量:17
  • 3Vissers B,Everaert J,Sekula1 J,et al.Unique potentiometric detection systems for HPLC determination of some steroids in human urine[J].Journal of Separation Science,2009,32(2):167-179.
  • 4Franks S.Diagnosis of polycystic ovarian syndrome:In defence of the Rotterdam criteria[J].Clin Endocrinol Metab,2006,91(3):786-789.
  • 5Yildiz BO,Woods KS,Stanczyk F,et al.Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome[J].Clin Endocrinol Metab,2004,89(11):5558-5562.
  • 6刘逸超,丛晶,吴效科.卵巢源雄激素过多症和肾上腺源雄激素过多症[J].中国妇幼健康研究,2008,19(6):612-614. 被引量:1
  • 7Teede HJ,Meyer C,Norman RJ.Insulin-sensitisers in the treatment of polycystic ovary syndrome[J].Expert Opin Pharmacother,2005,6(14):2419-2427.
  • 8Azziz R,Carmina E,Dewailly D,et al.Position statement:criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome:an androgen excess society guideline[J].Clin Endocrinol Metab,2006,91(11):4237-4245.
  • 9Evanthia Diamanti-Kandarakis.Polycystic ovarian syndrome:pathophysiology,molecular aspects and clinical implications[J].Expert Reviews in Molecular Medicine,2008,10(2):e3.

二级参考文献20

  • 1朱桂金.黄体与黄体功能不全[J].国外医学(妇产科学分册),1993,20(5):264-268. 被引量:6
  • 2吴端宗,黄秋生,罗亚宁.不孕症妇女血清性激素含量变化及临床应用[J].现代检验医学杂志,2004,19(6):54-55. 被引量:7
  • 3Ferreira S R, Gimeno S G, Hirai A T, et al. Effects of an intervention in eating habits and physical activity in Japanese- Brazilian women with a high prevalence of metabolic syndrome in Bauru, S o Paulo State, Brazil[J]. Cad Saude Publica,2008,24 ( Suppl 2) : S294-S302.
  • 4Carmina E. Mild androgen disorders [ J ]. Best Pract Res Clin Endocrinol Metab ,2006,20:207-220.
  • 5Azziz R, Sanchez L A, Knochenhauer E S, et al. Androgen excess in women: Experience with over 1 000 consecutive patients [ J ]. Clin Endocrinol Metab,2004,89:453-462.
  • 6Carmina, Rosato E F, Janni A, et al. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism[ J]. Clin Endocrinol Metab,2005,91 : 2-6.
  • 7Escobar M H F, Luque R M, San M J L. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome [ J ]. Endocr Rev,2005 ,26 :251-282.
  • 8Abbott D H, Barnett D K, Brims C M, et al. Androgen excess fetal programming of female reproduction: A developmental etiology for polycystic ovary syndrome[ J ]. Hum Reprod Update ,2005,11 : 357- 374.
  • 9Andreas M, Louis J G, Susanne N S, et al. Prevalence of polycystic ovary syndrome (PCOS) and hyperandrogenemia in female-to-male transsexuals [ J ]. Clin Endocrin Metab ,2008,93 (4) : 1408 -1411.
  • 10Kumar A, Woods K S, Bartolucci A A, et al. Prevalence of adrenal androgen excess in patients With the polycystic ovary syndrome (PCOS) [ J]. Clin. Endocrinol (Oxf) ,2005,62:644-649.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部